Genomic Surveillance and Antigenic Characterization of Respiratory Syncytial Virus (RSV) in Spain During the 2023-2024 Season of Nirsevimab Administration.
Iglesias-Caballero M, Mas V, Campoy A, Calvo C, García ML, Alcolea S, Moreno-Parrado L, Reina J, Navascués A, Antón A, Davina-Nunez C, Perez-Castro S, Costa J, Fernández-González A, Lepe JA, Gaona C, Pérez Z, García-Martínez de Artola D, Vázquez-Morón S, Camarero S, Cano O, Pozo F, Casas I.
Iglesias-Caballero M, et al. Among authors: navascues a.
J Infect Dis. 2026 Feb 18;233(2):e409-e418. doi: 10.1093/infdis/jiaf530.
J Infect Dis. 2026.
PMID: 41103028
Free PMC article.